Targeting the gut microbiota to alleviate chemotherapy-induced toxicity in cancer

References

• An L, Wuri J, Zheng Z, Li W, Yan T. 2021. Microbiota modulate doxorubicin induced cardiotoxicity. Eur J Pharm Sci. 166:105977. doi:10.1016/j.ejps.2021.105977.
   PubMed Web of Science ®Google Scholar
• Bastos RW, Pedroso SH, Vieira AT, Moreira LM, Franca CS, Cartelle CT, Arantes RM, Generoso SV, Cardoso VN, Neves MJ, et al. 2016. Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis. Benef Microbes. 7(4):549–557. doi:10.3920/BM2015.0190.
   PubMed Web of Science ®Google Scholar
• Bhatt AP, Redinbo MR, Bultman SJ. 2017. The role of the microbiome in cancer development and therapy. CA Cancer J Clin. 67(4):326–344. doi:10.3322/caac.21398.
   PubMed Web of Science ®Google Scholar
• Bowen JM, Stringer AM, Gibson RJ, Yeoh AS, Hannam S, Keefe DM. 2007. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther. 6(9):1449–1454. doi:10.4161/cbt.6.9.4622.
   PubMed Web of Science ®Google Scholar
• Chamseddine AN, Ducreux M, Armand JP, Paoletti X, Satar T, Paci A, Mir O. 2019. Intestinal bacterial beta-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity. Pharmacol Ther. 199:1–15. doi:10.1016/j.pharmthera.2019.03.002.
   PubMed Web of Science ®Google Scholar
• Chang CW, Lee HC, Li LH, Chiang Chiau JS, Wang TE, Chuang WH, Chen MJ, Wang HY, Shih SC, Liu CY, et al. 2020. Fecal microbiota transplantation prevents intestinal injury, upregulation of toll-like receptors, and 5-fluorouracil/oxaliplatin-induced toxicity in colorectal cancer. IJMS. 21(2):386. doi:10.3390/ijms21020386.
   Google Scholar
• Chang CW, Liu CY, Lee HC, Huang YH, Li LH, Chiau JC, Wang TE, Chu CH, Shih SC, Tsai TH, et al. 2018. Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model. Front Microbiol. 9:983. doi:10.3389/fmicb.2018.00983.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang F, Li R, Liu Y, Wang X, Zhang X, Xu C, Li Y, Guo Y, Yao Q. 2020. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota. Biomed Pharmacother. 124:109829. doi:10.1016/j.biopha.2020.109829.
   PubMed Web of Science ®Google Scholar
• Chen X, Sun W, Xu B, Wu E, Cui Y, Hao K, Zhang G, Zhou C, Xu Y, Li J, et al. 2021. Polysaccharides from the roots of millettia speciosa champ modulate gut health and ameliorate cyclophosphamide-induced intestinal injury and immunosuppression. Front Immunol. 12:766296. doi:10.3389/fimmu.2021.766296.
   PubMed Web of Science ®Google Scholar
• Cheng KW, Tseng CH, Tzeng CC, Leu YL, Cheng TC, Wang JY, Chang JM, Lu YC, Cheng CM, Chen IJ, et al. 2019. Pharmacological inhibition of bacterial beta-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo. Pharmacol Res. 139:41–49. doi:10.1016/j.phrs.2018.10.029.
   PubMed Web of Science ®Google Scholar
• Cho I, Blaser MJ. 2012. The human microbiome: at the interface of health and disease. Nat Rev Genet. 13(4):260–270. doi:10.1038/nrg3182.
   PubMed Web of Science ®Google Scholar
• Chovanec M, Abu Zaid M, Hanna N, El-Kouri N, Einhorn LH, Albany C. 2017. Long-term toxicity of cisplatin in germ-cell tumor survivors. Ann Oncol. 28(11):2670–2679. doi:10.1093/annonc/mdx360.
   PubMed Web of Science ®Google Scholar
• Cryan JF, O’Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, et al. 2019. The microbiota-gut-brain axis. Physiol Rev. 99(4):1877–2013. doi:10.1152/physrev.00018.2018.
   PubMed Web of Science ®Google Scholar
• Daillere R, Vetizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C, Lepage P, Roberti MP, et al. 2016. Enterococcus hirae and barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity. 45(4):931–943. doi:10.1016/j.immuni.2016.09.009.
   PubMed Web of Science ®Google Scholar
• De Jesus LCL, Drumond MM, de Carvalho A, Santos SS, Martins FS, Ferreira Ê, Fernandes RS, de Barros ALB, do Carmo FLR, Perez PF, et al. 2019. Protective effect of Lactobacillus delbrueckii subsp. Lactis CIDCA 133 in a model of 5 Fluorouracil-Induced intestinal mucositis. J Funct Foods. 53:197–207. doi:10.1016/j.jff.2018.12.027.
   Web of Science ®Google Scholar
• Dessalvi CC, Deidda M, Mele D, Bassareo PP, Esposito R, Santoro C, Lembo M, Galderisi M, Mercuro G. 2018. Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention. J Cardiovasc Med. 19(7):315–323. doi:10.2459/JCM.0000000000000667.
   Google Scholar
• Diasio RB. 1998. Sorivudine and 5-fluorouracil: a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase. Br J Clin Pharmacol. 46(1):1–4. doi:10.1046/j.1365-2125.1998.00050.x.
   PubMed Web of Science ®Google Scholar
• Dvořák Z, Sokol H, Mani S. 2020. Drug mimicry: promiscuous receptors PXR and AhR, and microbial metabolite interactions in the intestine. Trends Pharmacol Sci. 41(12):900–908. doi:10.1016/j.tips.2020.09.013.
   PubMed Web of Science ®Google Scholar
• Ervin SM, Hanley RP, Lim L, Walton WG, Pearce KH, Bhatt AP, James LI, Redinbo MR. 2019. Targeting Regorafenib-Induced Toxicity through Inhibition of Gut Microbial beta-Glucuronidases. ACS Chem Biol. 14(12):2737–2744. doi:10.1021/acschembio.9b00663.
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. 2021. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 19(1):55–71. doi:10.1038/s41579-020-0433-9.
   PubMed Web of Science ®Google Scholar
• Ferreira TM, Leonel AJ, Melo MA, Santos RRG, Cara DC, Cardoso VN, Correia M, Alvarez-Leite JI. 2012. Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-fluorouracil administration. Lipids. 47(7):669–678. doi:10.1007/s11745-012-3680-3.
   PubMed Web of Science ®Google Scholar
• Fijlstra M, Ferdous M, Koning AM, Rings EH, Harmsen HJ, Tissing WJ. 2015. Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model. Support Care Cancer. 23(6):1513–1522. doi:10.1007/s00520-014-2487-6.
   PubMed Web of Science ®Google Scholar
• Frank M, Hennenberg EM, Eyking A, Runzi M, Gerken G, Scott P, Parkhill J, Walker AW, Cario E. 2015. TLR signaling modulates side effects of anticancer therapy in the small intestine. J Immunol. 194(4):1983–1995. doi:10.4049/jimmunol.1402481.
   PubMed Web of Science ®Google Scholar
• Funk MA, Baker DH. 1991. Effect of fiber, protein source and time of feeding on methotrexate toxicity in rats. J Nutr. 121(10):1673–1683. doi:10.1093/jn/121.10.1673.
   PubMed Web of Science ®Google Scholar
• Gallotti B, Galvao I, Leles G, Quintanilha MF, Souza RO, Miranda VC, Rocha VM, Trindade LM, Jesus LCL, Mendes V, et al. 2021. Effects of dietary fibre intake in chemotherapy-induced mucositis in murine model. Br J Nutr. 126(6):853–864. doi:10.1017/S0007114520004924.
   PubMed Web of Science ®Google Scholar
• Galloway-Pena JR, Shi Y, Peterson CB, Sahasrabhojane P, Gopalakrishnan V, Brumlow CE, Daver NG, Alfayez M, Boddu PC, Khan MAW, et al. 2020. Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia. Clin Infect Dis. 71(1):63–71. doi:10.1093/cid/ciz777.
   PubMed Web of Science ®Google Scholar
• Ganesh BP, Klopfleisch R, Loh G, Blaut M. 2013. Commensal Akkermansia muciniphila Exacerbates Gut Inflammation in Salmonella Typhimurium-Infected Gnotobiotic Mice. PLoS One. 8(9):e74963. doi:10.1371/journal.pone.0074963.
   PubMed Web of Science ®Google Scholar
• Grant CV, Loman BR, Bailey MT, Pyter LM. 2021. Manipulations of the gut microbiome alter chemotherapy-induced inflammation and behavioral side effects in female mice. Brain Behav Immun. 95:401–412. doi:10.1016/j.bbi.2021.04.014.
   PubMed Web of Science ®Google Scholar
• Hagan T, Cortese M, Rouphael N, Boudreau C, Linde C, Maddur MS, Das J, Wang H, Guthmiller J, Zheng NY, et al. 2019. Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans. Cell. 178(6):1313–1328 e1313. doi:10.1016/j.cell.2019.08.010.
   PubMed Web of Science ®Google Scholar
• Hakim H, Dallas R, Wolf J, Tang L, Schultz-Cherry S, Darling V, Johnson C, Karlsson EA, Chang TC, Jeha S, et al. 2018. Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia. Clin Infect Dis. 67(4):541–548. doi:10.1093/cid/ciy153.
   PubMed Web of Science ®Google Scholar
• Hamouda N, Sano T, Oikawa Y, Ozaki T, Shimakawa M, Matsumoto K, Amagase K, Higuchi K, Kato S. 2017. Apoptosis, dysbiosis and expression of inflammatory cytokines are sequential events in the development of 5-fluorouracil-induced intestinal mucositis in mice. Basic Clin Pharmacol Toxicol. 121(3):159–168. doi:10.1111/bcpt.12793.
   PubMed Web of Science ®Google Scholar
• He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, Dong X, Huang J, Wang Q, Mackay CR, et al. 2021. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity. Cell Metab. 33(5):988–1000 e1007. doi:10.1016/j.cmet.2021.03.002.
   PubMed Web of Science ®Google Scholar
• Hsiao YP, Chen HL, Tsai JN, Lin MY, Liao JW, Wei MS, Ko JL, Ou CC. 2021. Administration of lactobacillus reuteri combined with Clostridium butyricum attenuates cisplatin-induced renal damage by gut microbiota reconstitution, increasing butyric acid production, and suppressing renal inflammation. Nutrients. 13(8):2792. doi:10.3390/nu13082792.
   PubMed Web of Science ®Google Scholar
• Huang F, Li S, Chen W, Han Y, Yao Y, Yang L, Li Q, Xiao Q, Wei J, Liu Z, et al. 2023. Postoperative probiotics administration attenuates gastrointestinal complications and gut microbiota dysbiosis caused by chemotherapy in colorectal cancer patients. Nutrients. 15(2):356. doi:10.3390/nu15020356.
   PubMed Web of Science ®Google Scholar
• Huang J, Wei S, Jiang C, Xiao Z, Liu J, Peng W, Zhang B, Li W. 2022. Involvement of abnormal gut microbiota composition and function in doxorubicin-induced cardiotoxicity. Front Cell Infect Microbiol. 12:808837. doi:10.3389/fcimb.2022.808837.
   PubMed Web of Science ®Google Scholar
• Huang K, Liu Y, Tang H, Qiu M, Li C, Duan C, Wang C, Yang J, Zhou X. 2019. Glabridin prevents doxorubicin-induced cardiotoxicity through gut microbiota modulation and colonic macrophage polarization in mice. Front Pharmacol. 10:107. doi:10.3389/fphar.2019.00107.
   PubMed Web of Science ®Google Scholar
• Hueso T, Ekpe K, Mayeur C, Gatse A, Curt MJC, Gricourt G, Rodriguez C, Burdet C, Ulmann G, Neut C, et al. 2020. Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening. Gut Microbes. 12(1):1800897. doi:10.1080/19490976.2020.1800897.
   PubMed Web of Science ®Google Scholar
• Ianiro G, Rossi E, Thomas AM, Schinzari G, Masucci L, Quaranta G, Settanni CR, Lopetuso LR, Armanini F, Blanco-Miguez A, et al. 2020. Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma. Nat Commun. 11(1):4333. doi:10.1038/s41467-020-18127-y.
   PubMed Web of Science ®Google Scholar
• Justino PF, Melo LF, Nogueira AF, Costa JV, Silva LM, Santos CM, Mendes WO, Costa MR, Franco AX, Lima AA, et al. 2014. Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice. Br J Nutr. 111(9):1611–1621. doi:10.1017/S0007114513004248.
   PubMed Web of Science ®Google Scholar
• Justino PF, Melo LF, Nogueira AF, Morais CM, Mendes WO, Franco AX, Souza EP, Ribeiro RA, Souza MH, Soares PM. 2015. Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice. Cancer Chemother Pharmacol. 75(3):559–567. doi:10.1007/s00280-014-2663-x.
   PubMed Web of Science ®Google Scholar
• Kaczmarek A, Brinkman BM, Heyndrickx L, Vandenabeele P, Krysko DV. 2012. Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways. J Pathol. 226(4):598–608. doi:10.1002/path.3009.
   PubMed Web of Science ®Google Scholar
• Kato S, Hamouda N, Kano Y, Oikawa Y, Tanaka Y, Matsumoto K, Amagase K, Shimakawa M. 2017. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses. Clin Exp Pharmacol Physiol. 44(10):1017–1025. doi:10.1111/1440-1681.12792.
   PubMed Web of Science ®Google Scholar
• Ke W, Saba JA, Yao CH, Hilzendeger MA, Drangowska-Way A, Joshi C, Mony VK, Benjamin SB, Zhang S, Locasale J, et al. 2020. Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion. Nat Commun. 11(1):2587. doi:10.1038/s41467-020-16220-w.
   PubMed Web of Science ®Google Scholar
• Kolodziejczyk AA, Zheng DP, Elinav E. 2019. Diet-microbiota interactions and personalized nutrition. Nat Rev Microbiol. 17(12):742–753. doi:10.1038/s41579-019-0256-8.
   PubMed Web of Science ®Google Scholar
• Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, et al. 2014. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 120(10):1453–1461. doi:10.1002/cncr.28592.
   PubMed Web of Science ®Google Scholar
• Lee TH, Park D, Kim YJ, Lee I, Kim S, Oh CT, Kim JY, Yang J, Jo SK. 2020. Lactobacillus salivarius BP121 prevents cisplatininduced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and pcresol sulfate via alleviating dysbiosis. Int J Mol Med. 45(4):1130–1140. doi:10.3892/ijmm.2020.4495.
   PubMed Web of Science ®Google Scholar
• Li HL, Lu L, Wang XS, Qin LY, Wang P, Qiu SP, Wu H, Huang F, Zhang BB, Shi HL, et al. 2017. Alteration of gut microbiota and inflammatory cytokine/chemokine profiles in 5-fluorouracil induced intestinal mucositis. Front Cell Infect Microbiol. 7:455. doi:10.3389/fcimb.2017.00455.
   PubMed Web of Science ®Google Scholar
• Lin H, Meng L, Sun Z, Sun S, Huang X, Lin N, Zhang J, Lu W, Yang Q, Chi J, et al. 2021. Yellow wine polyphenolic compound protects against doxorubicin-induced cardiotoxicity by modulating the composition and metabolic function of the gut microbiota. Circ Heart Failure. 14(10):e008220. doi:10.1161/CIRCHEARTFAILURE.120.008220.
   Web of Science ®Google Scholar
• Lin XB, Farhangfar A, Valcheva R, Sawyer MB, Dieleman L, Schieber A, Ganzle MG, Baracos V. 2014. The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats. PLoS One. 9(1):e83644. doi:10.1371/journal.pone.0083644.
   PubMed Web of Science ®Google Scholar
• Liu T, Wu Y, Wang L, Pang X, Zhao L, Yuan H, Zhang C. 2019. A More Robust Gut Microbiota in Calorie-Restricted Mice Is Associated with Attenuated Intestinal Injury Caused by the Chemotherapy Drug Cyclophosphamide. mBio. 10(2):e02903-18. doi:10.1128/mBio.02903-18.
   Web of Science ®Google Scholar
• Loman BR, Jordan KR, Haynes B, Bailey MT, Pyter LM. 2019. Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice. Sci Rep. 9(1):16490. doi:10.1038/s41598-019-52893-0.
   PubMedGoogle Scholar
• Lu Q, Lai J, Lu H, Ng C, Huang T, Zhang H, Ding K, Wang Z, Jiang J, Hu J, et al. 2019. Gut Microbiota in bipolar depression and its relationship to brain function: an advanced exploration. Front Psychiatry. 10:784. doi:10.3389/fpsyt.2019.00784.
   PubMed Web of Science ®Google Scholar
• Manno RA, Grassetti A, Oberto G, Nyska A, Ramot Y. 2016. The minipig as a new model for the evaluation of doxorubicin-induced chronic toxicity. J Appl Toxicol. 36(8):1060–1072. doi:10.1002/jat.3266.
   PubMed Web of Science ®Google Scholar
• Mao Y, Kasravi B, Nobaek S, Wang LQ, Adawi D, Roos G, Stenram U, Molin G, Bengmark S, Jeppsson B. 1996. Pectin-supplemented enteral diet reduces the severity of methotrexate induced enterocolitis in rats. Scand J Gastroenterol. 31(6):558–567. doi:10.3109/00365529609009128.
   PubMed Web of Science ®Google Scholar
• Mao Y, Nobaek S, Kasravi B, Adawi D, Stenram U, Molin G, Jeppsson B. 1996. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology. 111(2):334–344. doi:10.1053/gast.1996.v111.pm8690198.
   PubMed Web of Science ®Google Scholar
• Marsova M, Odorskaya M, Novichkova M, Polyakova V, Abilev S, Kalinina E, Shtil A, Poluektova E, Danilenko V. 2020. The Lactobacillus brevis 47 f strain protects the murine intestine from enteropathy induced by 5-fluorouracil. Microorganisms. 8(6):876. doi:10.3390/microorganisms8060876.
   PubMed Web of Science ®Google Scholar
• Mauger CA, Butler RN, Geier MS, Tooley KL, Howarth GS. 2007. Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats. Dig Dis Sci. 52(3):612–619. doi:10.1007/s10620-006-9464-y.
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 122(1):107–118. doi:10.1016/j.cell.2005.05.007.
   PubMed Web of Science ®Google Scholar
• Mego M, Chovanec J, Vochyanova-Andrezalova I, Konkolovsky P, Mikulova M, Reckova M, Miskovska V, Bystricky B, Beniak J, Medvecova L, et al. 2015. Prevention of irinotecan induced diarrhea by probiotics: a randomized double blind, placebo controlled pilot study. Complement Ther Med. 23(3):356–362. doi:10.1016/j.ctim.2015.03.008.
   PubMed Web of Science ®Google Scholar
• Mego M, Ebringer L, Drgona L, Mardiak J, Trupl J, Greksak R, Nemova I, Oravcova E, Zajac V, Koza I. 2005. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. Neoplasma. 52(2):159–164.
   PubMed Web of Science ®Google Scholar
• Mego M, Koncekova R, Mikuskova E, Drgona L, Ebringer L, Demitrovicova L, Nemova I, Trupl J, Mardiak J, Koza I, et al. 2006. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study. Support Care Cancer. 14(3):285–290. doi:10.1007/s00520-005-0891-7.
   PubMed Web of Science ®Google Scholar
• Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. 2004. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 56(2):185–229. doi:10.1124/pr.56.2.6.
   PubMed Web of Science ®Google Scholar
• Montassier E, Al-Ghalith GA, Ward T, Corvec S, Gastinne T, Potel G, Moreau P, de la Cochetiere MF, Batard E, Knights D. 2016. Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection. Genome Med. 8(1):49. doi:10.1186/s13073-016-0301-4.
   PubMed Web of Science ®Google Scholar
• Montemurro F, Mittica G, Cagnazzo C, Longo V, Berchialla P, Solinas G, Culotta P, Martinello R, Foresto M, Gallizioli S, et al. 2016. Self-evaluation of adjuvant chemotherapy-related adverse effects by patients with breast cancer. JAMA Oncol. 2(4):445–452. doi:10.1001/jamaoncol.2015.4720.
   PubMed Web of Science ®Google Scholar
• Naito S, Koga H, Yamaguchi A, Fujimoto N, Hasui Y, Kuramoto H, Iguchi A, Kinukawa N, Kyushu University Urological Oncology G. 2008. Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer. J Urol. 179(2):485–490. doi:10.1016/j.juro.2007.09.031.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Kinouchi T, Kataoka K, Akimoto S, Matsuda Y, Ohnishi Y. 1997. Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil. Pharmacogenetics. 7(1):35–43. doi:10.1097/00008571-199702000-00005.
   PubMedGoogle Scholar
• Niu QY, Li ZY, Du GH, Qin XM. 2016. (1)H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model. J Pharm Biomed Anal. 118:338–348. doi:10.1016/j.jpba.2015.10.026.
   PubMed Web of Science ®Google Scholar
• Nozaki N, Shishido T, Takeishi Y, Kubota I. 2004. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation. 110(18):2869–2874. doi:10.1161/01.CIR.0000146889.46519.27.
   PubMed Web of Science ®Google Scholar
• Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I, Joensuu H. 2007. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer. 97(8):1028–1034. doi:10.1038/sj.bjc.6603990.
   PubMed Web of Science ®Google Scholar
• Pannu AK. 2019. Methotrexate overdose in clinical practice. Curr Drug Metab. 20(9):714–719. doi:10.2174/1389200220666190806140844.
   PubMed Web of Science ®Google Scholar
• Pearce A, Haas M, Viney R, Pearson SA, Haywood P, Brown C, Ward R. 2017. Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study. PLoS One. 12(10):e0184360. doi:10.1371/journal.pone.0184360.
   PubMed Web of Science ®Google Scholar
• Quaresma M, Damasceno S, Monteiro C, Lima F, Mendes T, Lima M, Justino P, Barbosa A, Souza M, Souza E, et al. 2020. Probiotic mixture containing Lactobacillus spp. and Bifidobacterium spp. attenuates 5-fluorouracil-induced intestinal mucositis in mice. Nutr Cancer. 72(8):1355–1365. doi:10.1080/01635581.2019.1675719.
   PubMed Web of Science ®Google Scholar
• Ramakrishna C, Corleto J, Ruegger PM, Logan GD, Peacock BB, Mendonca S, Yamaki S, Adamson T, Ermel R, McKemy D, et al. 2019. Dominant role of the gut microbiota in chemotherapy induced neuropathic pain. Sci Rep. 9(1):20324. doi:10.1038/s41598-019-56832-x.
   PubMedGoogle Scholar
• Ren X, Liu L, Liu P, Gamallat Y, Xin Y, Shang D. 2018. Polysaccharide extracted from Enteromorpha ameliorates Cisplastin-induced small intestine injury in mice. J Funct Foods. 49:154–161. doi:10.1016/j.jff.2018.08.023.
   Web of Science ®Google Scholar
• Reyna-Figueroa J, Barron-Calvillo E, Garcia-Parra C, Galindo-Delgado P, Contreras-Ochoa C, Lagunas-Martinez A, Campos-Romero FH, Silva-Estrada JA, Limon-Rojas AE. 2019. Probiotic Supplementation Decreases Chemotherapy-induced Gastrointestinal Side Effects in Patients With Acute Leukemia. J Pediatr Hematol Oncol. 41(6):468–472. doi:10.1097/MPH.0000000000001497.
   PubMed Web of Science ®Google Scholar
• Rigby RJ, Carr J, Orgel K, King SL, Lund PK, Dekaney CM. 2016. Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis. Gut Microbes. 7(5):414–423. doi:10.1080/19490976.2016.1215806.
   PubMed Web of Science ®Google Scholar
• Rooks MG, Garrett WS. 2016. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 16(6):341–352. doi:10.1038/nri.2016.42.
   PubMed Web of Science ®Google Scholar
• Round JL, Mazmanian SK. 2010. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 107(27):12204–12209. doi:10.1073/pnas.0909122107.
   PubMed Web of Science ®Google Scholar
• Roy S, Trinchieri G. 2017. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 17(5):271–285. doi:10.1038/nrc.2017.13.
   PubMed Web of Science ®Google Scholar
• Sakura T, Hayakawa F, Sugiura I, Murayama T, Imai K, Usui N, Fujisawa S, Yamauchi T, Yujiri T, Kakihana K, et al. 2018. High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG. Leukemia. 32(3):626–632. doi:10.1038/leu.2017.283.
   PubMed Web of Science ®Google Scholar
• Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, Sanders ME, Shamir R, Swann JR, Szajewska H, et al. 2021. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 18(9):649–667. doi:10.1038/s41575-021-00440-6.
   PubMed Web of Science ®Google Scholar
• Sezer A, Usta U, Cicin I. 2009. The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea. Med Oncol. 26(3):350–357. doi:10.1007/s12032-008-9128-1.
   PubMed Web of Science ®Google Scholar
• Sharma A, Tilak T, Bakhshi S, Raina V, Kumar L, Chaudhary S, Sahoo R, Gupta R, Thulkar S. 2016. Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation. ESMO Open. 1(6):e000138. doi:10.1136/esmoopen-2016-000138.
   PubMedGoogle Scholar
• Shen S, Lim G, You Z, Ding W, Huang P, Ran C, Doheny J, Caravan P, Tate S, Hu K, et al. 2017. Gut microbiota is critical for the induction of chemotherapy-induced pain. Nat Neurosci. 20(9):1213–1216. doi:10.1038/nn.4606.
   PubMed Web of Science ®Google Scholar
• Shi H, Chang Y, Gao Y, Wang X, Chen X, Wang Y, Xue C, Tang Q. 2017. Dietary fucoidan of Acaudina molpadioides alters gut microbiota and mitigates intestinal mucosal injury induced by cyclophosphamide. Food Funct. 8(9):3383–3393. doi:10.1039/c7fo00932a.
   PubMed Web of Science ®Google Scholar
• Sorbara MT, Pamer EG. 2022. Microbiome-based therapeutics. Nat Rev Microbiol. 20(6):365–380. doi:10.1038/s41579-021-00667-9.
   PubMed Web of Science ®Google Scholar
• Sougiannis AT, VanderVeen BN, Enos RT, Velazquez KT, Bader JE, Carson M, Chatzistamou I, Walla M, Pena MM, Kubinak JL, et al. 2019. Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota. Brain Behav Immun. 80:44–55. doi:10.1016/j.bbi.2019.02.020.
   PubMed Web of Science ®Google Scholar
• Subramaniam CB, Bowen JM, Gladman MA, Lustberg MB, Mayo SJ, Wardill HR. 2020. The microbiota-gut-brain axis: an emerging therapeutic target in chemotherapy-induced cognitive impairment. Neurosci Biobehav Rev. 116:470–479. doi:10.1016/j.neubiorev.2020.07.002.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 71(3):209–249. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Tang D, Zeng T, Wang Y, Cui H, Wu J, Zou B, Tao Z, Zhang L, Garside GB, Tao S. 2020. Dietary restriction increases protective gut bacteria to rescue lethal methotrexate-induced intestinal toxicity. Gut Microbes. 12(1):1714401. doi:10.1080/19490976.2020.1714401.
   PubMed Web of Science ®Google Scholar
• Tang Y, Wu Y, Huang Z, Dong W, Deng Y, Wang F, Li M, Yuan J. 2017. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats. Nutrition. 33:96–104. doi:10.1016/j.nut.2016.05.003.
   PubMed Web of Science ®Google Scholar
• Tao J, Li S, Gan RY, Zhao CN, Meng X, Li HB. 2020. Targeting gut microbiota with dietary components on cancer: effects and potential mechanisms of action. Crit Rev Food Sci Nutr. 60(6):1025–1037. doi:10.1080/10408398.2018.1555789.
   PubMed Web of Science ®Google Scholar
• Teillant A, Gandra S, Barter D, Morgan DJ, Laxminarayan R. 2015. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis. 15(12):1429–1437. doi:10.1016/S1473-3099(15)00270-4.
   PubMed Web of Science ®Google Scholar
• Thaiss CA, Zmora N, Levy M, Elinav E. 2016. The microbiome and innate immunity. Nature. 535(7610):65–74. doi:10.1038/nature18847.
   PubMed Web of Science ®Google Scholar
• Tian Y, Li M, Song W, Jiang R, Li YQ. 2019. Effects of probiotics on chemotherapy in patients with lung cancer. Oncol Lett. 17(3):2836–2848. doi:10.3892/ol.2019.9906.
   PubMed Web of Science ®Google Scholar
• Tsilimigras MC, Fodor A, Jobin C. 2017. Carcinogenesis and therapeutics: the microbiota perspective. Nat Microbiol. 2:17008. doi:10.1038/nmicrobiol.2017.8.
   PubMed Web of Science ®Google Scholar
• Uzan-Yulzari A, Morr M, Tareef-Nabwani H, Ziv O, Magid-Neriya D, Armoni R, Muller E, Leibovici A, Borenstein E, Louzoun Y, et al. 2020. The intestinal microbiome, weight, and metabolic changes in women treated by adjuvant chemotherapy for breast and gynecological malignancies. BMC Med. 18(1):281. doi:10.1186/s12916-020-01751-2.
   PubMed Web of Science ®Google Scholar
• Valdes AM, Walter J, Segal E, Spector TD. 2018. Role of the gut microbiota in nutrition and health. BMJ. 361:k2179. doi:10.1136/bmj.k2179.
   PubMedGoogle Scholar
• van Vliet MJ, Tissing WJE, Dun CAJ, Meessen NEL, Kamps WA, de Bont E, Harmsen HJM. 2009. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis. 49(2):262–270. doi:10.1086/599346.
   PubMed Web of Science ®Google Scholar
• Vanhoefer U, Harstrick A, Achterrath W, Cao SS, Seeber S, Rustum YM. 2001. Irinotecan in the treatment of colorectal cancer: clinical overview. J Clin Oncol. 19(5):1501–1518. doi:10.1200/JCO.2001.19.5.1501.
   PubMed Web of Science ®Google Scholar
• Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, et al. 2013. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 342(6161):971–976. doi:10.1126/science.1240537.
   PubMed Web of Science ®Google Scholar
• Wallace BD, Wang HW, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh LA, Mani S, et al. 2010. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 330(6005):831–835. doi:10.1126/science.1191175.
   PubMed Web of Science ®Google Scholar
• Wang D, Li D, Zhang Y, Chen J, Zhang Y, Liao C, Qin S, Tian Y, Zhang Z, Xu F. 2021. Functional metabolomics reveal the role of AHR/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage. Acta Pharm Sin B. 11(3):763–780. doi:10.1016/j.apsb.2020.07.017.
   PubMed Web of Science ®Google Scholar
• Wang J, Feng W, Zhang S, Chen L, Sheng Y, Tang F, He J, Xu X, Ao H, Peng C. 2019. Ameliorative effect of Atractylodes macrocephala essential oil combined with Panax ginseng total saponins on 5-fluorouracil induced diarrhea is associated with gut microbial modulation. J Ethnopharmacol. 238:111887. doi:10.1016/j.jep.2019.111887.
   PubMed Web of Science ®Google Scholar
• Wang L, Chen Q, Qi H, Wang C, Wang C, Zhang J, Dong L. 2016. Doxorubicin-Induced systemic inflammation is driven by upregulation of toll-like receptor TLR4 and endotoxin leakage. Cancer Res. 76(22):6631–6642. doi:10.1158/0008-5472.CAN-15-3034.
   PubMed Web of Science ®Google Scholar
• Wang L, Dong XL, Qin XM, Li ZY. 2022. Investigating the inter-individual variability of Astragali Radix against cisplatin-induced liver injury via 16S rRNA gene sequencing and LC/MS-based metabolomics. Phytomedicine. 101:154107. doi:10.1016/j.phymed.2022.154107.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang R, Wei GY, Wang SM, Du GH. 2020. Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice. Biomed Pharmacother. 128:110262. doi:10.1016/j.biopha.2020.110262.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun L, Chen S, Guo S, Yue T, Hou Q, Feng M, Xu H, Liu Y, Wang P, et al. 2019. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice. Life Sci. 231:116529. doi:10.1016/j.lfs.2019.06.004.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC, et al. 2018. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med. 24(12):1804–1808. doi:10.1038/s41591-018-0238-9.
   PubMed Web of Science ®Google Scholar
• Wang ZN, Zhao YZ. 2018. Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell. 9(5):416–431. doi:10.1007/s13238-018-0549-0.
   PubMed Web of Science ®Google Scholar
• Wardill HR, Gibson RJ, Van Sebille YZA, Secombe KR, Coller JK, White IA, Manavis J, Hutchinson MR, Staikopoulos V, Logan RM, et al. 2016. Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms. Mol Cancer Ther. 15(6):1376–1386. doi:10.1158/1535-7163.MCT-15-0990.
   PubMed Web of Science ®Google Scholar
• Wardill HR, van der Aa SAR, da Silva Ferreira AR, Havinga R, Tissing WJE, Harmsen HJM. 2021. Antibiotic-induced disruption of the microbiome exacerbates chemotherapy-induced diarrhoea and can be mitigated with autologous faecal microbiota transplantation. Eur J Cancer. 153:27–39. doi:10.1016/j.ejca.2021.05.015.
   PubMed Web of Science ®Google Scholar
• Wilson ID, Nicholson JK. 2017. Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl Res. 179:204–222. doi:10.1016/j.trsl.2016.08.002.
   PubMed Web of Science ®Google Scholar
• Wong DV, Lima-Junior RC, Carvalho CB, Borges VF, Wanderley CW, Bem AX, Leite CA, Teixeira MA, Batista GL, Silva RL, et al. 2015. The adaptor protein Myd88 is a key signaling molecule in the pathogenesis of irinotecan-induced intestinal mucositis. PLoS One. 10(10):e0139985. doi:10.1371/journal.pone.0139985.
   PubMed Web of Science ®Google Scholar
• Wong DVT, Holanda RBF, Cajado AG, Bandeira AM, Pereira JFB, Amorim JO, Torres CS, Ferreira LMM, Lopes MHS, Oliveira RTG, et al. 2021. TLR4 deficiency upregulates TLR9 expression and enhances irinotecan-related intestinal mucositis and late-onset diarrhoea. Br J Pharmacol. 178(20):4193–4209. doi:10.1111/bph.15609.
   PubMed Web of Science ®Google Scholar
• Wu J, Gan Y, Li M, Chen L, Liang J, Zhuo J, Luo H, Xu N, Wu X, Wu Q, et al. 2020. Patchouli alcohol attenuates 5-fluorouracil-induced intestinal mucositis via TLR2/MyD88/NF-kB pathway and regulation of microbiota. Biomed Pharmacother. 124:109883. doi:10.1016/j.biopha.2020.109883.
   PubMed Web of Science ®Google Scholar
• Wu X, Zhang N, Kan J, Tang S, Sun R, Wang Z, Chen M, Liu J, Jin C. 2022. Polyphenols from Arctium lappa L ameliorate doxorubicin-induced heart failure and improve gut microbiota composition in mice. J Food Biochem. 46(3):e13731. doi:10.1111/jfbc.13731.
   PubMed Web of Science ®Google Scholar
• Xia T, Zhang J, Han L, Jin Z, Wang J, Li X, Man S, Liu C, Gao W. 2019. Protective effect of magnolol on oxaliplatin-induced intestinal injury in mice. Phytother Res. 33(4):1161–1172. doi:10.1002/ptr.6311.
   PubMed Web of Science ®Google Scholar
• Xiong RG, Huang SY, Wu SX, Zhou DD, Yang ZJ, Saimaiti A, Zhao CN, Shang A, Zhang YJ, Gan RY, et al. 2022. Anticancer effects and mechanisms of berberine from medicinal herbs: an update review. Molecules. 27(14):4523. doi:10.3390/molecules27144523.
   PubMed Web of Science ®Google Scholar
• Xu XF, Zhang XW. 2015. Effects of cyclophosphamide on immune system and gut microbiota in mice. Microbiol Res. 171:97–106. doi:10.1016/j.micres.2014.11.002.
   PubMed Web of Science ®Google Scholar
• Yan A, Culp E, Perry J, Lau JT, MacNeil LT, Surette MG, Wright GD. 2018. Transformation of the anticancer drug doxorubicin in the human gut microbiome. ACS Infect Dis. 4(1):68–76. doi:10.1021/acsinfecdis.7b00166.
   PubMed Web of Science ®Google Scholar
• Yang ZJ, Huang SY, Zhou DD, Xiong RG, Zhao CN, Fang AP, Zhang YJ, Li HB, Zhu HL. 2022. Effects and mechanisms of curcumin for the prevention and management of cancers: an updated review. Antioxidants (Basel). 11(8):1481. doi:10.3390/antiox11081481.
   PubMedGoogle Scholar
• Yeung CY, Chiang Chiau JS, Cheng ML, Chan WT, Chang SW, Chang YH, Jiang CB, Lee HC. 2020. Modulations of probiotics on gut microbiota in a 5-fluorouracil-induced mouse model of mucositis. J Gastroenterol Hepatol. 35(5):806–814. doi:10.1111/jgh.14890.
   PubMed Web of Science ®Google Scholar
• Yu C, Zhou B, Xia X, Chen S, Deng Y, Wang Y, Wu L, Tian Y, Zhao B, Xu H, et al. 2019. Prevotella copri is associated with carboplatin-induced gut toxicity. Cell Death Dis. 10(10):714. doi:10.1038/s41419-019-1963-9.
   PubMedGoogle Scholar
• Yu Z, Yu XF, Kerem G, Ren PG. 2022. Perturbation on gut microbiota impedes the onset of obesity in high fat diet-induced mice. Front Endocrinol. 13:795371. doi:10.3389/fendo.2022.795371.
   PubMed Web of Science ®Google Scholar
• Yuan KT, Yu HL, Feng WD, Chong P, Yang T, Xue CL, Yu M, Shi HP. 2015. Bifidobacterium infantis has a beneficial effect on 5-fluorouracil-induced intestinal mucositis in rats. Benef Microbes. 6(1):113–118. doi:10.3920/BM2013.0095.
   PubMed Web of Science ®Google Scholar
• Yue B, Gao R, Lv C, Yu Z, Wang H, Geng X, Wang Z, Dou W. 2021. Berberine improves irinotecan-induced intestinal mucositis without impairing the anti-colorectal cancer efficacy of irinotecan by inhibiting bacterial beta-glucuronidase. Front Pharmacol. 12:774560. doi:10.3389/fphar.2021.774560.
   PubMed Web of Science ®Google Scholar
• Zeng X, Yang X, Fan JJ, Tan Y, Ju LY, Shen WX, Wang YL, Wang XH, Chen WP, Ju DW, et al. 2021. MASI: microbiota-active substance interactions database. Nucleic Acids Res. 49(D1):D776–D782. doi:10.1093/nar/gkaa924.
   PubMed Web of Science ®Google Scholar
• Zhang C, Xiong B, Chen L, Ge W, Yin S, Feng Y, Sun Z, Sun Q, Zhao Y, Shen W, et al. 2021. Rescue of male fertility following faecal microbiota transplantation from alginate oligosaccharide-dosed mice. Gut. 70(11):2213–2215. doi:10.1136/gutjnl-2020-323593.
   PubMed Web of Science ®Google Scholar
• Zhang F, Chen H, Zhang R, Liu Y, Kong N, Guo Y, Xu M. 2020. 5-Fluorouracil induced dysregulation of the microbiome-gut-brain axis manifesting as depressive like behaviors in rats. Biochim Biophys Acta Mol Basis Dis. 1866(10):165884. doi:10.1016/j.bbadis.2020.165884.
   PubMed Web of Science ®Google Scholar
• Zhang F, Cui B, He X, Nie Y, Wu K, Fan D, Group FM-s, FMT-standardization Study Group. 2018. Microbiota transplantation: concept, methodology and strategy for its modernization. Protein Cell. 9(5):462–473. doi:10.1007/s13238-018-0541-8.
   PubMed Web of Science ®Google Scholar
• Zhang M, Liu D, Zhou H, Liu X, Li X, Cheng Y, Gao B, Chen J. 2021. Intestinal flora characteristics of advanced non-small cell lung cancer in China and their role in chemotherapy based on metagenomics: a prospective exploratory cohort study. Thorac Cancer. 12(24):3293–3303. doi:10.1111/1759-7714.14199.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhou H, Xu S, Liu D, Cheng Y, Gao B, Li X, Chen J. 2020. The gut microbiome can be used to predict the gastrointestinal response and efficacy of lung cancer patients undergoing chemotherapy. Ann Palliat Med. 9(6):4211–4227. doi:10.21037/apm-20-2183.
   PubMed Web of Science ®Google Scholar
• Zhang P, Feng Y, Li L, Ge W, Yu S, Hao Y, Shen W, Han X, Ma D, Yin S, et al. 2021. Improvement in sperm quality and spermatogenesis following faecal microbiota transplantation from alginate oligosaccharide dosed mice. Gut. 70(1):222–225. doi:10.1136/gutjnl-2020-320992.
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu J, Xiong B, Zhang C, Kang B, Gao Y, Li Z, Ge W, Cheng S, Hao Y, et al. 2020. Microbiota from alginate oligosaccharide-dosed mice successfully mitigated small intestinal mucositis. Microbiome. 8(1):112. doi:10.1186/s40168-020-00886-x.
   PubMed Web of Science ®Google Scholar
• Zhang T, Lu SH, Bi Q, Liang L, Wang YF, Yang XX, Gu W, Yu J. 2017. Volatile oil from amomi fructus attenuates 5-fluorouracil-induced intestinal mucositis. Front Pharmacol. 8:786. doi:10.3389/fphar.2017.00786.
   PubMed Web of Science ®Google Scholar
• Zhao L, Xing C, Sun W, Hou G, Yang G, Yuan L. 2018. Lactobacillus supplementation prevents cisplatin-induced cardiotoxicity possibly by inflammation inhibition. Cancer Chemother Pharmacol. 82(6):999–1008. doi:10.1007/s00280-018-3691-8.
   PubMed Web of Science ®Google Scholar
• Zhou B, Xia X, Wang P, Chen S, Yu C, Huang R, Zhang R, Wang Y, Lu L, Yuan F, et al. 2018. Induction and amelioration of methotrexate-induced gastrointestinal toxicity are related to immune response and gut microbiota. EBioMedicine. 33:122–133. doi:10.1016/j.ebiom.2018.06.029.
   PubMed Web of Science ®Google Scholar
• Zidi O, Souai N, Raies H, Ben Ayed F, Mezlini A, Mezrioui S, Tranchida F, Sabatier JM, Mosbah A, Cherif A, et al. 2021. Fecal metabolic profiling of breast cancer patients during neoadjuvant chemotherapy reveals potential biomarkers. Molecules. 26(8):2266. doi:10.3390/molecules26082266.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Daillere R, Roberti MP, Routy B, Kroemer G. 2017. Anticancer effects of the microbiome and its products. Nat Rev Microbiol. 15(8):465–478. doi:10.1038/nrmicro.2017.44.
   PubMed Web of Science ®Google Scholar